{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-020177","form_type":"8-K","ticker":"TRVI","cik":"0001563880","company_name":"Trevi Therapeutics, Inc.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.214995+00:00","generated_at":"2026-06-25T14:48:31.109320+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Trevi Therapeutics expands at-the-market equity facility by $50M to $62M total","bullets":["Amended Sales Agreement with SVB Securities to increase max aggregate offering from $12M to $62M, adding $50M in capacity.","Shares sold in ATM offerings under Rule 415; SVB receives 3.0% commission on gross proceeds.","Company will file a prospectus supplement under existing shelf registration statement (File No. 333-239499).","No obligation to sell; either party may suspend the offering at any time.","SVB affiliate Silicon Valley Bank is lender under a separate $14M term loan."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-020177","json":"https://secwatch.observer/filing/0001564590-22-020177.json","markdown":"https://secwatch.observer/filing/0001564590-22-020177.md","text":"https://secwatch.observer/filing/0001564590-22-020177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022020177/0001564590-22-020177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022020177/trvi-8k_20220513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T14:48:31.109320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}